Cited by 30Substance Abuse Treatment and OutcomesHIV, Drug Use, Sexual RiskOpioid Use Disorder Treatment

Reducing non-injection drug use in HIV primary care: a randomized trial of brief motivational interviewing, with and without HealthCall, a technology-based enhancement

Open access
Aharonovich, Efrat, Sarvet, Aaron, Stohl, Malki, DesJarlais, Don, Tross, Susan, Hurst, Teresa, Urbina, Antonio, Hasin, Deborah·2017·Journal of Substance Abuse Treatment

Abstract

Aims In HIV-infected individuals, non-injection drug use (NIDU) compromises many health outcomes. In HIV primary care, the efficacy of brief motivational interviewing (MI) to reduce NIDU is unknown, and drug users may need greater intervention. We designed an enhancement to MI, HealthCall (HC), for daily patient self-monitoring calls to an interactive voice response (IVR) phone system, and provided participants with periodic personalized feedback. To reduce NIDU among HIV primary care patients, we compared the efficacy of MI+HealthCall to MI-only and an educational control condition.Design Participants age >18 with >4days of NIDU during the prior 30days were recruited from large urban HIV primary care clinics. Of the 240 participants, 83 were randomly assigned to control, 77 to MI-only, and 80 to MI+HC. Counselors provided educational control, MI-only or MI+HC at baseline. At 30 and 60days (end-of-treatment), counselors briefly discussed drug use, moods and health behaviors, using HealthCall-generated graphs with MI+HC patients. Primary outcomes (last 30days) were number of days used primary drug (NumDU), and total quantity of primary drug used (dollar amount spent; QuantU), derived from the Time-Line Follow-Back.Findings Across all groups, at end-of-treatment, frequency and quantity of NIDU decreased, with significantly greater reductions in the MI-Only group. A twelve-month post-treatment follow-up indicated sustained benefits of MI+HC and MI-only relative to control.Conclusions Brief interventions can be successfully used to reduce non-injection drug use in HIV primary care. IVR-based technology may not be sufficiently engaging to be effective. Future studies should investigate mobile technology to deliver a more engaging version of HealthCall to diverse substance abusing populations.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jsat.2016.12.009

Cites

62 of 62 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Aharonovich, E., Sarvet, A., Stohl, M., DesJarlais, D., Tross, S., Hurst, T., Urbina, A., & Hasin, D.
Affiliations
  • Columbia University Irving Medical Center (US)
  • New York State Psychiatric Institute (US)
  • Icahn School of Medicine at Mount Sinai (US)
  • Mount Sinai Health System (US)
Corresponding author
Aharonovich, Efrat
Venue
Journal of Substance Abuse Treatment
Publisher
Elsevier BV
Published
2017-03
Volume
74
Pages
71-79
ISSN
0740-5472 (ISSN-L)
OpenAlex
W2567060720
Cited by
30
References
61
Citations by year
2026: 1 · 2025: 3 · 2024: 2 · 2023: 6 · 2022: 3 · 2021: 2 · 2020: 5 · 2019: 3 · 2018: 1 · 2017: 4
FWCI
2.50
Type
journal article
Language
en
Open access
Locations
  • Journal of Substance Abuse Treatment (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institute on Alcohol Abuse and Alcoholism (R01AA014323, R01AA023163)
  • National Institute on Drug Abuse (R01DA024606, T32DA031099, P30DA011041)
Topics
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Health Sciences › Medicine › Epidemiology › HIV, Drug Use, Sexual Risk
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
Keywords
non-injection drug use, HIV primary care, motivational interviewing, interactive voice response, patient self-monitoring, personalized feedback, brief intervention, substance use reduction, people living with HIV, mobile health technology
MeSH terms
Adult, Female, Follow-Up Studies, Humans, Male, Middle Aged, Primary Health Care, Telephone, HIV Infections, Outcome Assessment, Health Care, Substance-Related Disorders, Motivational Interviewing

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review